PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma

Overview of attention for article published in Clinical Cancer Research, February 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 17,296)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 48 news outlets
twitter: 6 X users
patent: 7 patents

facebook: 1 Facebook page
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 174 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

MEANS AND METHODS FOR THE QUANTIFICATION OF TARGET EXPRESSION

Application WO-2026008886-A1

World Intellectual Property Organisation (WIPO)

08 Jan 2026

COMBINATION OF ANTIGEN SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS

Application WO-2023025779-A1

World Intellectual Property Organisation (WIPO)

02 Mar 2023

COMBINATION OF PRAME SPECIFIC T CELL RECEPTORS AND CHIMERIC CO-STIMULATORY RECEPTORS

Application WO-2022234116-A1

World Intellectual Property Organisation (WIPO)

10 Nov 2022

METHODS AND COMPOSITIONS FOR PREDICTING AND TREATING UVEAL MELANOMA

Application WO-2022101481-A1

World Intellectual Property Organisation (WIPO)

19 May 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.